|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/2866 | (2013.01) | ||
| A61P 29/00 | (2006.01) | ||
| C07K2317/21 | (2013.01) | ||
| G01N 33/53 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61M 5/00 | (2006.01) | ||
| A61K2039/54 | (2013.01) | ||
| A61K2039/545 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| G01N2800/347 | (2013.01) | ||
| G01N2800/52 | (2013.01) | ||
| G01N 33/564 | (2013.01) | ||
| G01N2800/104 | (2013.01) | ||
| A61M 5/20 | (2013.01) | ||
| A61M 5/142 | (2013.01) |
| (11) | Number of the document | 4192882 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22724712.9 |
| Date of filing the European patent application | 2022-04-22 | |
| (97) | Date of publication of the European application | 2023-06-14 |
| (45) | Date of publication and mention of the grant of the patent | 2025-02-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2022/060670 |
| Date | 2022-04-22 |
| (87) | Number | WO 2022/223771 |
| Date | 2022-10-27 |
| (30) | Number | Date | Country code |
| 202163178745 P | 2021-04-23 | US | |
| 202163221986 P | 2021-07-15 | US | |
| 202163270091 P | 2021-10-21 | US |
| (72) |
LINDHOLM, Catharina , SE
CHIA, Yen Lin , US
TUMMALA, Rajendra , US
ROSKOS, Lorin , US
ALMQUIST, Joachim , SE
ROUSE, Tomas , SE
TRASIEVA, Teodora , SE
WHITE, Wendy , US
SINIBALDI, Dominic , US
RAMASWAMY, Madhu , US
NEWCOMBE, Paul , GB
|
| (73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
|
| (54) | TREATMENT OF LUPUS NEPHRITIS WITH ANTI-TYPE I INF RECEPTOR ANTIBODY ANIFROLUMAB |
| TREATMENT OF LUPUS NEPHRITIS WITH ANTI-TYPE I INF RECEPTOR ANTIBODY ANIFROLUMAB |